Skip to main content

Table 4 Occurrence of hypercalciuria according to calcium and/or vitamin D supplementation (top) and baseline menopausal status (bottom)

From: Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer

Vitamin D and/or calcium supplementation (N = 66)
  Yes (n = 9) No (n = 58) p-value
Hypercalciuria
No 5 62.5 [20.8–91.3] 38 65.5 [52.1–76.9] 0.7
Yes 3 37.5 [8.7–79.2] 20 34.5 [23.1–47.9]
Baseline Menopausal status (N = 81)
  Yes (n = 46) No (n = 35)  
Hypercalciuria
No 30 65.2 [50–77.9] 23 65.7 [47.9–80] 0.4
Yes 16 34.8 [22.1–50] 12 34.3 [20–52.1]